17.44
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
Syndax Pharmaceuticals, Inc.'s (NASDAQ:SNDX) Shares Climb 29% But Its Business Is Yet to Catch Up - simplywall.st
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 1-Year HighHere's Why - MarketBeat
Is Syndax Pharmaceuticals Inc. stock poised for growthWeekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com
How Syndax Pharmaceuticals Inc. (1T3) stock compares with tech leadersWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Syndax at Jefferies: Strategic Growth in Hematologic Therapies By Investing.com - Investing.com Canada
Is Syndax Pharmaceuticals Inc. stock attractive for ETFsJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
How Syndax Pharmaceuticals Inc. (1T3) stock gains from tech spendingJuly 2025 Recap & Daily Price Action Insights - newser.com
Why (SNDX) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
How Syndax Pharmaceuticals Inc. (1T3) stock trades under stagflationJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Is Syndax Pharmaceuticals Inc. stock reversal real or fakeMarket Activity Recap & Daily Technical Forecast Reports - newser.com
What insider purchases suggest about Syndax Pharmaceuticals Inc. (1T3) stockQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - newser.com
How Syndax Pharmaceuticals Inc. stock performs in stagflation2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-11-19 00:07:46 - newser.com
Knott David M Jr Has $3.30 Million Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Is Syndax Pharmaceuticals Inc. (1T3) stock undervalued by metrics2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Why ETFs are accumulating Syndax Pharmaceuticals Inc. (1T3) stockJobs Report & Weekly Breakout Opportunity Watchlist - newser.com
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Syndax Pharmaceuticals (SNDX): Assessing Value After Revuforj FDA Expansion and Revenue Surge - Yahoo Finance
Is it too late to sell Syndax Pharmaceuticals Inc.2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com
How Syndax Pharmaceuticals Inc. stock performs in rate cut cyclesWeekly Trading Summary & Risk Controlled Stock Pick Alerts - newser.com
Campbell & CO Investment Adviser LLC Invests $439,000 in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains "Overweight" Rating - Finviz
JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains “Overweight” Rating - Insider Monkey
Using Ichimoku Cloud for Syndax Pharmaceuticals Inc. technicalsBond Market & Growth-Oriented Investment Plans - newser.com
Will Syndax Pharmaceuticals Inc. stock maintain momentum in 20252025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Fox Run Management L.L.C. Buys Shares of 18,363 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):